2004
DOI: 10.1200/jco.2004.22.14_suppl.8075
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and safety of long-term, once-daily morphine sulfate extended-release capsules in cancer patients with chronic, moderate-to-severe pain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2006
2006

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…78 In an openlabel trial, effectiveness and good tolerability was reported in cancer patients, and a randomized controlled trial reported improved quality of sleep compared with twice-daily morphine. 79,80 An ER liposome injection of morphine sulfate is now available for single-dose administration by the epidural route, at the lumbar level, for the treatment of pain following major surgery. This formulation uses DepoFoam technology to provide extended drug release from a liposomal depot after a single-dose injection.…”
Section: New Medications and Formulationsmentioning
confidence: 99%
“…78 In an openlabel trial, effectiveness and good tolerability was reported in cancer patients, and a randomized controlled trial reported improved quality of sleep compared with twice-daily morphine. 79,80 An ER liposome injection of morphine sulfate is now available for single-dose administration by the epidural route, at the lumbar level, for the treatment of pain following major surgery. This formulation uses DepoFoam technology to provide extended drug release from a liposomal depot after a single-dose injection.…”
Section: New Medications and Formulationsmentioning
confidence: 99%